BioNTech and Fosun Pharma announced start of clinical trial of mRNA-based COVID-19 vaccine candidate in China
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
-
-
Pfizer and BioNTech to supply Canada with their BNT162 mRNA- based vaccine candidate
On Aug. 5, 2020, Pfizer Canada and BioNTech SE today announced an agreement with the Government of Canada…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
-
GSK and CureVac announced strategic mRNA technology collaboration
On Jul. 21, 2020, GlaxoSmithKline and CureVac announced the signing of a strategic collaboration agreement for the research, development,…
-
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
-
Sanofi and Translate Bio expanded collaboration and license agreement to develop mRNA vaccines for infectious diseases
On Jun. 23, 2020, Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage…
-
Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
-
Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel Coronavirus
On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…
-
Arcturus Therapeutics and Catalent announced partnership to manufacture mRNA-Based COVID-19 vaccine
On May 4, 2020, Arcturus Therapeutics and Catalent announced a partnership to support the expected manufacture of Arcturus’…
-
Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
-
NIH grant awarded to Georgia Tech researchers to develop mRNA-based drug to correct hematopoietic stem cells
On Oct. 1, 2019, the National Institutes of Health (NIH) awarded a $3.5 million grant to Georgia Institute…
-
Joan Steitz discovered snRNPs
In 1979, Joan Steitz discovered snRNPs, RNA-protein complexes in the cell’s nucleus that perform a crucial step in…
